Immunomodulatory effects of egg white enzymatic hydrolysates containing immunodominant epitopes in a BALB/c mouse model of egg allergy

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 6, 2009, Pages 2241-2248

  Yang, Marie ^a   Yang, Chengbo ^a   Nau, Francoise ^c   Pasco, Maryvonne ^c   Juneja, Lekh R ^b   Okubo, Tutomu ^b   Mine, Yoshinori ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b AGROCAMPUS OUEST   (France)

^c TAIYO KAGAKU CO LTD   (Japan)

Author keywords

Egg allergy; Enzymatic hydrolysate; Epitopes; Immunomodulation; Regulatory T cells

Indexed keywords

CYTOKINE; EGG PROTEIN; EPITOPE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; PROTEIN HYDROLYSATE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; SECRETION; SPLEEN;

AMINO ACID SEQUENCE; ANIMALS; CYTOKINES; EGG PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HISTAMINE; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN HYDROLYSATES; SPLEEN;

MUS;

EID: 64549158929     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803372b     Document Type: Article

References (30)

1. Kovacs-Nolan, J.; Phillips, M.; Mine, Y. Advances in the value of eggs and egg components for human health. J. Agric. Food Chem. 2005, 53, 8421-8431.
2. Mine, Y. Egg proteins and peptides in human health - chemistry, bioactivity and production. Curr. Pharm. Des. 2007, 13, 875-884.
3. Holgate, S. T.; Polosa, R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 2008, 8, 218-230.
4. Sicherer, S. H.; Sampson, H. A. Food allergy. J. Allergy Clin. Immunol. 2006, 117, S470-475.
5. Eggesbø, M.; Botten, G.; Halvorsen, R.; Magnus, P. The prevalence of allergy to egg: a population-based study in young children. Allergy 2001, 56, 403-411.
6. Heine, R. G.; Laske, N.: Hill, D. J. The diagnosis and management of egg allergy. Curr. Allergy Asthma Rep. 2006, 6, 145-152.
7. Sampson, H. A. Update on food allergy. J Allergy Clin. Immunol. 2004, 113, 805-819.
8. Sicherer, S. H.; Sampson, H. A. Food allergy: recent advances in pathophysiology and treatment. Annu. Rev. Med. 2008, 60, 261-277.
9. Mine, Y.; Yang, M. Recent advances in the understanding of egg allergens: basic, industrial, and clinical perspectives. J. Agric. Food Chem. 2008, 56, 4874-4900.
10. Eigenmann, P. Future therapeutic options in food allergy. Allergy 2003, 58, 1217-1223.
11. Osborn, D. A.; Sinn, J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst. Rev. 2006, 18, CD003664.
12. Rupa, P.: Mine, Y. Engineered recombinant ovomucoid third domain can desensitize Balb/c mice of egg allergy. Allergy 2006, 61, 836-842.
13. Mine, Y.; Yang, M. Epitope characterization of ovalbumin in BALB/c mice using different entry routes. Biochim. Biophys. Acta 2007, 1774, 200-211.
14. Adel-Patient, K.; Créminon, C.; Boquet, D.; Wal, J. M.; Chatel, J. M. Prevention of an IgE response to bovine β-lactoglobulin by gene immunization in mice. Allerg. Immunol. (Paris) 2002, 34, 77-81.
15. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001, 25, 402-408.
16. Beyer. K. Hypoallergenicity: a principle for the treatment of food allergy. Nestle Nutr. Workshop Ser: Pediatr. Prog. 2007, 59, 37-43.
17. Walker-Smith, J. Hypoallergenic formulas: are they really hy-poallergenic? Ann. Allergy Asthma Immunol. 2003, 90, 112-114.
18. Yang, M.; Mine, Y. Novel T-cell epitopes of ovalbumin in BALB/c mouse: potential for peptide-immunotherapy. Biochem. Biophys. Res. Commun. 2009, 378, 203-208.
19. Shevach, E. M.; Davidson, T. S.; Huter, E. N.; Dipaolo, R. A.; Andersson, J. Role of TGF-β in the induction of Foxp3 expression and T regulatory cell function. J. Clin. Immunol. 2008, 28, 640-646.
20. Oldfield, W. L.; Larche, M.; Kay, A. B. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002, 360, 47-53.
21. Francis, J. N.: Till, S. J.; Durham, S. R. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 2003, 111, 1255-1261.
22. Verhagen, J.; Blaser, K.; Akdis, C. A.; Akdis, M. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more. Immunol. Allergy Clin. North Am. 2006, 26, 207-213.
23. Gorelik, L.; Fields, P. E.; Flavell, R. A. Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 2000, 165, 4773-4777.
24. Gorelik, L.; Constant, S.; Flavell, R. A. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 2002, 195, 1499-1505.
25. Fantini, M. C.; Becker, C.; Tubbe, I.; Nikolaev, A.; Lehr, H. A.: Galle, P.; Neurath, M. F. Transforming growth factorβ induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006, 55, 671-680.
26. Paik, Y.; Dahl, M.; Fang, D.; Calhoun, K. Update: the role of FoxP3 in allergic disease. Curr. Opin. Otolaryngol. Head Neck Surg. 2008, 16, 275-279.
27. Tanabe, S. Epitope peptides and immunotherapy. Curr. Protein Pept. Sci. 2007, 8, 109-118.
28. Vrtala, S.; Focke-Tejkl, M.; Swoboda, I.; Kraft, D.; Valenta, R. Strategies for converting allergens into hypoallergenic vaccine candidates. Methods 2004, 32, 313-320.
29. Focke, M.; Mahler, V.; Ball, T.; Sperr, W. R.: Majlesi, Y.; Valent, P.; Kraft, D.; Valenta, R. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J. 2001, 15, 2042-2044.
30. Focke, M.; Linhart, B.; Hartl, A.; Wiedermann, U.; Sperr, W. R.; Valent, P.; Thalhamer, J.; Kraft, D.; Valenta, R. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen. Bet v 1, for preventive vaccination. Clin. Exp. Allergy 2004, 34, 1525-1533.